Home > Boards > US Listed > Medical - Drugs > Antares Pharma, Inc. (ATRS)

2020 is an election year. When both republican

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
gi197845 Member Profile
 
Followed By 4
Posts 2,227
Boards Moderated 3
Alias Born 08/16/16
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 1:19:20 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/11/2020 7:08:02 AM
Antares Pharma Announces Full-Year 2020 Net Revenue Guidance Range of $135 to $155 Million GlobeNewswire Inc. - 1/27/2020 7:00:10 AM
Antares Pharma Appoints Edward Tykot Senior Vice President, Corporate Development GlobeNewswire Inc. - 12/10/2019 7:00:10 AM
Antares Pharma Social Media Campaign for XYOSTED® Wins MarCom Platinum Award GlobeNewswire Inc. - 12/6/2019 7:00:10 AM
Antares Pharma to Present at the 31st Annual Piper Jaffray Healthcare Conference GlobeNewswire Inc. - 11/27/2019 5:51:22 PM
Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd. GlobeNewswire Inc. - 11/19/2019 7:00:00 AM
Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd. GlobeNewswire Inc. - 11/19/2019 1:00:00 AM
Antares Pharma to Present at the Jefferies 2019 London Healthcare Conference GlobeNewswire Inc. - 11/13/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2019 4:16:28 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2019 7:31:28 AM
Antares Pharma Reports Third Quarter 2019 Operating and Financial Results GlobeNewswire Inc. - 11/5/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/4/2019 7:02:13 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/4/2019 7:00:22 AM
Antares Pharma Announces Receipt of Final Payment From Sale of Zomajet™ Needle-Free Delivery System GlobeNewswire Inc. - 10/31/2019 7:00:05 AM
Antares Pharma to Report Third Quarter 2019 Financial and Operating Results GlobeNewswire Inc. - 10/29/2019 7:00:05 AM
Gazit Globe Offer to Acquire All Minority Shareholder Interests in Subsidiary Atrium Has Not Been Approved GlobeNewswire Inc. - 10/25/2019 10:41:10 AM
Antares Pharma Announces Two Poster Presentations at the 2019 Sexual Medicine Society Scientific Annual Meeting GlobeNewswire Inc. - 10/24/2019 7:00:05 AM
Gazit Globe Reaffirms its Commitment and Price GlobeNewswire Inc. - 10/11/2019 2:41:57 PM
Antares Pharma to Present at the Ladenburg Thalmann 2019 Healthcare Conference GlobeNewswire Inc. - 9/17/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2019 5:01:34 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2019 4:02:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2019 7:06:56 AM
Antares Pharma Reports Second Quarter 2019 Operating and Financial Results GlobeNewswire Inc. - 8/6/2019 7:00:00 AM
Antares Pharma to Report Second Quarter 2019 Financial and Operating Results GlobeNewswire Inc. - 7/30/2019 7:00:00 AM
gi197845   Thursday, 12/05/19 09:23:29 PM
Re: None
Post # of 4745 
2020 is an election year. When both republican and democrat candidates target big pharma drug prices as the evil enemy (even though drug development costs are high) how will that screw over our profitability, in terms of causing the stock price going down and not up.

Remember, in 2015 Hillary tweeted that drug prices need to come down and that she was going to take on big pharma and that very same day, big pharma stocks tanked down at least 6% and I suspect much more.

Isn't it a dangerous as hell risk to be invested in big pharma in 2020?

If Trump runs and wins, wouldn't that bode well for being invested in fossil fuel stocks instead?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist